info@synchemia.com | sales@synchemia.com 
9766925136 
Fluvoxamine
Fluvoxamine is primarily used medically for the treatment of several conditions, primarily related to mental health Such as Obsessive-Compulsive Disorder (OCD), Major Depressive Disorder (MDD), Panic Disorder, Fluvoxamine belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). It works by increasing the levels of serotonin, a neurotransmitter in the brain that is involved in regulating mood, emotions and behavior.
"Synchemia specializes in the supply of Fluvoxamine impurities that meet specific pharmacopeial standards (EP/BP/USP/IP), as well as process-related impurities. Fluvoxamine is a medication used to treat mental health and Synchemia ensuring the purity and quality of its impurities that are crucial for pharmaceutical manufacturing companies for regulatory compliance."
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-F6018 |
| CAS No | 88699-85-8 |
| Mol.F. | C15H20F3NO3 |
| Mol.Wt. | 319.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6019 |
| CAS No | 89035-92-7 |
| Mol.F. | C15H21F3N2O2 : C4H4O4 |
| Mol.Wt. | 318.3 : 116.1 |
| INV STATUS | IN STOCK |
| CAT No | SRC-F6020 |
| CAS No | 1613218-80-6 |
| Mol.F. | C21H31F3N2O4 |
| Mol.Wt. | 432.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6021 |
| CAS No | 1217241-15-0 |
| Mol.F. | C17H17F3N2O : C4H4O4 |
| Mol.Wt. | 322.3 : 116.07 |
| INV STATUS | IN STOCK |
| CAT No | SRC-F6022 |
| CAS No | NA |
| Mol.F. | C16H24F3N3O : 2(C4H4O4) |
| Mol.Wt. | 331.4 : 2(116.1)g/mole |
| INV STATUS | IN STOCK |
| CAT No | SRC-F6023 |
| CAS No | 1391053-78-3 |
| Mol.F. | C13H16F2O2 |
| Mol.Wt. | 242.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6024 |
| CAS No | NA |
| Mol.F. | C13H15F3O2 |
| Mol.Wt. | 260.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6025 |
| CAS No | NA |
| Mol.F. | C17H25F3N2O |
| Mol.Wt. | 330.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6026 |
| CAS No | NA |
| Mol.F. | C16H24F3N3O2 : C4H4O4 |
| Mol.Wt. | 347.4 : 116.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6027 |
| CAS No | 42916-66-5 |
| Mol.F. | C12H13F3O |
| Mol.Wt. | 230.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6028 |
| CAS No | NA |
| Mol.F. | C26H30F6O4 |
| Mol.Wt. | 520.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6029 |
| CAS No | 1349218-60-5 |
| Mol.F. | C15H23F3N2O3 |
| Mol.Wt. | 336.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6030 |
| CAS No | NA |
| Mol.F. | C15H21F3N2O2 |
| Mol.Wt. | 318.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6031 |
| CAS No | NA |
| Mol.F. | C15H21F3N2O2 |
| Mol.Wt. | 318.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-F6032 |
| CAS No | 1076198-14-5 |
| Mol.F. | C19H23F3N2O5 |
| Mol.Wt. | 416.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
